| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |